Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 22 studies | 34% ± 14% | |
| astrocyte | 16 studies | 38% ± 18% | |
| oligodendrocyte | 15 studies | 41% ± 18% | |
| microglial cell | 14 studies | 47% ± 15% | |
| glutamatergic neuron | 12 studies | 55% ± 24% | |
| macrophage | 12 studies | 40% ± 19% | |
| oligodendrocyte precursor cell | 12 studies | 43% ± 19% | |
| GABAergic neuron | 11 studies | 59% ± 26% | |
| fibroblast | 10 studies | 32% ± 12% | |
| adipocyte | 9 studies | 43% ± 15% | |
| mast cell | 9 studies | 25% ± 8% | |
| epithelial cell | 8 studies | 27% ± 14% | |
| pericyte | 8 studies | 33% ± 13% | |
| smooth muscle cell | 8 studies | 29% ± 11% | |
| neuron | 7 studies | 43% ± 20% | |
| interneuron | 6 studies | 70% ± 22% | |
| B cell | 6 studies | 25% ± 9% | |
| ciliated cell | 6 studies | 24% ± 7% | |
| T cell | 6 studies | 33% ± 9% | |
| myeloid cell | 6 studies | 38% ± 14% | |
| endothelial cell of lymphatic vessel | 6 studies | 38% ± 11% | |
| monocyte | 5 studies | 36% ± 12% | |
| natural killer cell | 5 studies | 29% ± 8% | |
| type I pneumocyte | 5 studies | 28% ± 9% | |
| granule cell | 4 studies | 42% ± 10% | |
| retinal ganglion cell | 4 studies | 32% ± 16% | |
| retinal pigment epithelial cell | 4 studies | 38% ± 22% | |
| cardiac muscle cell | 4 studies | 29% ± 2% | |
| dendritic cell | 4 studies | 29% ± 4% | |
| amacrine cell | 4 studies | 36% ± 13% | |
| retina horizontal cell | 4 studies | 38% ± 15% | |
| retinal cone cell | 4 studies | 32% ± 13% | |
| retinal rod cell | 4 studies | 37% ± 11% | |
| club cell | 4 studies | 25% ± 10% | |
| type II pneumocyte | 4 studies | 23% ± 7% | |
| basal cell | 4 studies | 31% ± 19% | |
| GABAergic interneuron | 3 studies | 57% ± 8% | |
| progenitor cell | 3 studies | 38% ± 11% | |
| placental villous trophoblast | 3 studies | 70% ± 20% | |
| CD4-positive, alpha-beta T cell | 3 studies | 38% ± 6% | |
| CD8-positive, alpha-beta T cell | 3 studies | 29% ± 7% | |
| vein endothelial cell | 3 studies | 33% ± 18% | |
| GABAergic amacrine cell | 3 studies | 40% ± 17% | |
| Mueller cell | 3 studies | 42% ± 12% | |
| OFF-bipolar cell | 3 studies | 46% ± 19% | |
| glycinergic amacrine cell | 3 studies | 38% ± 14% | |
| endothelial cell of vascular tree | 3 studies | 37% ± 17% | |
| ependymal cell | 3 studies | 43% ± 16% | |
| alveolar macrophage | 3 studies | 51% ± 12% | |
| capillary endothelial cell | 3 studies | 26% ± 4% | |
| respiratory goblet cell | 3 studies | 31% ± 11% | |
| lymphocyte | 3 studies | 44% ± 18% | |
| muscle cell | 3 studies | 30% ± 20% | |
| mural cell | 3 studies | 39% ± 11% | |
| regulatory T cell | 3 studies | 30% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2156.41 | 1445 / 1445 | 99% | 21.75 | 181 / 183 |
| intestine | 100% | 2507.22 | 966 / 966 | 99% | 23.26 | 520 / 527 |
| brain | 99% | 2339.11 | 2628 / 2642 | 99% | 23.47 | 696 / 705 |
| lung | 100% | 2566.34 | 577 / 578 | 98% | 20.72 | 1134 / 1155 |
| stomach | 100% | 1653.25 | 359 / 359 | 98% | 21.27 | 280 / 286 |
| breast | 100% | 3367.48 | 459 / 459 | 97% | 35.77 | 1089 / 1118 |
| thymus | 100% | 3469.50 | 653 / 653 | 97% | 47.44 | 585 / 605 |
| pancreas | 99% | 1285.89 | 325 / 328 | 97% | 26.42 | 172 / 178 |
| bladder | 100% | 2613.67 | 21 / 21 | 95% | 20.84 | 477 / 504 |
| prostate | 100% | 2114.36 | 245 / 245 | 94% | 18.51 | 474 / 502 |
| kidney | 100% | 1885.54 | 89 / 89 | 94% | 21.56 | 849 / 901 |
| uterus | 100% | 3256.71 | 170 / 170 | 91% | 17.23 | 419 / 459 |
| skin | 100% | 3191.64 | 1809 / 1809 | 91% | 24.76 | 429 / 472 |
| adrenal gland | 100% | 2181.81 | 258 / 258 | 90% | 20.05 | 208 / 230 |
| ovary | 100% | 3785.85 | 180 / 180 | 87% | 11.34 | 372 / 430 |
| liver | 98% | 845.63 | 222 / 226 | 64% | 7.58 | 261 / 406 |
| adipose | 100% | 3213.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2848.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3387.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.24 | 1 / 1 |
| muscle | 98% | 1106.56 | 788 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 1308.13 | 835 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 19.09 | 41 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 13.70 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 78% | 11.38 | 62 / 80 |
| peripheral blood | 73% | 1544.97 | 679 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048013 | Biological process | ephrin receptor signaling pathway |
| GO_0030833 | Biological process | regulation of actin filament polymerization |
| GO_0007165 | Biological process | signal transduction |
| GO_0001953 | Biological process | negative regulation of cell-matrix adhesion |
| GO_0007162 | Biological process | negative regulation of cell adhesion |
| GO_0001570 | Biological process | vasculogenesis |
| GO_0000281 | Biological process | mitotic cytokinesis |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0008360 | Biological process | regulation of cell shape |
| GO_0048514 | Biological process | blood vessel morphogenesis |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0051252 | Biological process | regulation of RNA metabolic process |
| GO_0001726 | Cellular component | ruffle |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0051020 | Molecular function | GTPase binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005096 | Molecular function | GTPase activator activity |
| GO_0019870 | Molecular function | potassium channel inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0001784 | Molecular function | phosphotyrosine residue binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | RASA1 |
| Protein name | RASA1 protein Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP) RAS p21 protein activator 1 |
| Synonyms | RASA GAP |
| Description | FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Stimulates the GTPase of normal but not oncogenic Ras p21; this stimulation may be further increased in the presence of NCK1. . |
| Accessions | Q7Z4M2 E9PGC0 ENST00000506290.1 ENST00000274376.11 [P20936-1] ENST00000512763.5 [P20936-4] ENST00000515800.6 [P20936-3] Q05CU5 P20936 ENST00000456692.6 [P20936-2] |